Inaugural AIA Healthcare Summit 2026 unites leaders across healthcare, government and business to extend Singapore’s healthspan and advance purposeful longevity
SINGAPORE, Aug. 12, 2026 /PRNewswire/ -- AIA Singapore today successfully concluded its inaugural AIA Healthcare Summit 2026, bringing together more than 700 policymakers, clinical specialists, technology innovators, and corporate leaders at The Ritz-Carlton, Millenia Singapore. Centred on the landmark theme, "Purposeful Longevity: Advancing Holistic Health through Public-Private Partnerships," the AIA Healthcare Summit served as a national platform to...
Osara Health Marks 10 Years with Global Call to Make Cancer Support Beyond Treatment Standard
Launched to mark the company's 10th anniversary, Osara Health's Global Cancer Support Declaration has already secured signatures from healthcare professionals worldwide. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Osara Health, a global digital health company focused on the human experience of cancer care, marks 10 years since its founding with 527 healthcare...
PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
NANJING, China, Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The approval provides critical support for the precise identification and clinical medication of patients with NTRK fusion‑positive solid tumors. ...
RingConn Advances Wearable Health Research with New Study in Nature Portfolio Journal npj Digital Medicine
The study, "Large-scale bilateral cardiovascular monitoring via wearable rings," analyzes 97,559 valid ring-PPG samples from 1,810 participants, providing new insights into bilateral wearable sensing for cardiovascular monitoring. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- A major step toward overcoming long-standing accuracy bottlenecks in consumer wearables, a joint research team from Ninenovo (parent company of RingConn), Professor Cheng Chen's team...
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks. Notably, this marks the company's 9th PCC...
Beyang Closes Oversubscribed $30 Million Series A Financing
Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor and a novel ophthalmic therapy. CHENGDU, China, Aug. 12, 2026 /PRNewswire/ -- Beyang Therapeutics Co., Ltd. ("Beyang"), an AI-driven innovative drug R&D company dedicated to building a "DreamWorks" for innovative drug discovery, today announced...
SingHealth Launches Global Network for World-Class Healthcare Administrator Immersion and Development
SingHealth is working alongside nine leading academic medical centres and health systems worldwide to formalise a structured exchange programme for healthcare administrators. Administrators will spend six to eight weeks embedded inside these institutions across North America, Europe and Asia, working shoulder-to-shoulder with peers at some of the world's most advanced health systems. SingHealth will also host...
Senhwa’s CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research
TAIPEI and SAN DIEGO, Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). A multinational research team comprising investigators from Poland, Slovakia, France and Senhwa Biosciences in Taiwan found that, under specific cell-based experimental conditions, controlled light activation...
Introducing Oticon Reveal™ – the world’s first hearing aid powered by Dual AI
From only words to a richer world of sound SMØRUM, Denmark, Aug. 12, 2026 /PRNewswire/ -- Today, Oticon launches Oticon Reveal™, the world's first hearing aid powered by Dual AI, delivering crystal-clear speech and meaningful sounds in optimal balance, bringing hearing aid users closer to a natural hearing experience. Oticon Reveal™ – the world’s first...
Helfie AI Appoints Heavyweight Tech and Governance Leaders to its Board of Directors
Former Apple and Airbnb executive Patrick Gates and ex-Meta executive Sunita Parasuraman join as Non-Executive Directors, strengthening Helfie's technology and governance. MELBOURNE, Australia, Aug. 12, 2026 /PRNewswire/ -- Helfie AI ("Helfie"), an AI-powered preventative network transforming global healthcare via mobile, today announced the appointment of Patrick Gates and Sunita Parasuraman as...
